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Abstract 1 
Psychological distress is common following acquired brain injury (ABI), but the evidence base for 2 
psychotherapeutic interventions is small and equivocal. Positive psychotherapy aims to foster 3 
wellbeing by increasing experiences of pleasure, engagement and meaning. In this pilot trial, we 4 
investigated the feasibility and acceptability of brief positive psychotherapy in adults with ABI and 5 
emotional distress. Participants were randomised to brief positive psychotherapy plus usual 6 
treatment, or usual treatment only. Brief positive psychotherapy was delivered over eight individual 7 
out-patient sessions, by one research psychologist. A blinded assessor administered the Depression 8 
Anxiety Stress Scales (DASS-21) and Authentic Happiness Inventory (AHI) at five, nine and 20 9 
weeks post-baseline. Of 27 participants randomised (median age 57; 63% male; 82% ischaemic 10 
stroke survivors; median 5.7 months post-injury), 14 were assigned to positive psychotherapy, of 11 
whom 8 completed treatment. The intervention was feasible to deliver with excellent fidelity, and 12 
was acceptable to participants. Retention at 20 weeks was 63% overall. A full-scale trial would need 13 
to retain n=39 per group to end-point, to detect a significant difference in change scores on the 14 
DASS-21 Depression scale of 7 points (two-tailed alpha=0.05, power=0.80). Trials including an 15 
active control arm would require larger sample sizes. We conclude that a full-scale trial to investigate 16 
efficacy is warranted.  17 
 18 
Keywords Brain injury; stroke; positive psychology; psychotherapy; randomised controlled trial  19 
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Introduction 20 
Psychological distress is common in people with acquired brain injury (ABI) such as stroke or 21 
traumatic brain injury (TBI), and impacts negatively on long-term functional outcome. Frequency of 22 
depression and anxiety are high after stroke (Campbell Burton et al., 2013; Hackett & Pickles, 2014), 23 
and post-stroke depression is associated with worse functional outcome (Pohjasvaara, Vataja, 24 
Leppavuori, Kaste, & Erkinjuntti, 2001). Depression and anxiety are also common in adults with TBI 25 
(Jorge et al., 2004; Osborn, Mathias, & Fairweather-Schmidt, 2014), and presence of psychological 26 
ill-health has been linked with poorer outcome and increased disability up to seven years following 27 
TBI (Whitnall, McMillan, Murray, & Teasdale, 2006). In light of the association between 28 
psychological morbidity and poorer outcomes, it is important to address low mood and adjustment 29 
problems during the rehabilitation process. Psychology services are a key component of ABI 30 
rehabilitation, but the evidence base for specific psychotherapeutic methods in this population is 31 
small and equivocal. There is some evidence of benefit from psychological therapies, including 32 
cognitive-behavioural therapy and mindfulness-based cognitive therapy, in people with acquired 33 
brain injury (Bedard et al., 2014; Bradbury et al., 2008; Soo & Tate, 2007), but a Cochrane review of 34 
psychological therapies for post-stroke depression found no overall beneficial effect in three trials 35 
meeting their criteria (Hackett, Anderson, House, & Xia, 2008). A more recent trial of behavioural 36 
therapy for stroke survivors with aphasia and low mood reported beneficial effects (Thomas, Walker, 37 
Macniven, Haworth, & Lincoln, 2013). There remains a need for further high quality research 38 
investigating psychological interventions which are aimed at alleviating psychological morbidity 39 
following brain injury.  40 
Cognitive-behavioural therapy (CBT) is one of the most commonly used psychological 41 
therapies for the treatment of low mood, but there can be challenges in applying standard CBT 42 
methods in patients with ABI because of the concomitant presence of cognitive impairment and lack 43 
of insight. It has been argued that CBT can and should be adapted for the particular circumstances 44 
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and needs of people with ABI; for example, modified treatment frameworks have been described for 45 
the stroke population (Broomfield et al., 2011; Kneebone, 2015). It may also be helpful to 46 
conceptualise depression after ABI as an understandable reaction at a time when self-identity is 47 
under threat (Gracey, Evans, & Malley, 2009), and therefore to employ treatment approaches which 48 
aim to resolve this threat to the self by facilitating self-reflection and personal growth as part of the 49 
rehabilitation process.  50 
In recent years, there has been an increasing emphasis on the study of positive psychological 51 
attributes and personal growth, in what has become known as ‘positive psychology’. Following 52 
Seligman and Csikszentmihalyi’s initial overview (Seligman & Csikszentmihalyi, 2000), growing 53 
interest in positive psychology has been reflected in the proliferation of books, journals, associations 54 
and  conferences dedicated to the topic. Positive psychology aims to understand the factors that 55 
underlie wellbeing, and positive emotions, character traits and organisations. Positive psychotherapy 56 
is a recently developed intervention approach (Rashid & Seligman, 2013) which is intended to 57 
reduce distress and foster wellbeing by increasing experiences of pleasure, engagement and meaning. 58 
Therapeutic exercises focus on experiences such as gratitude, savouring and optimism, and using 59 
character strengths in new ways. A recent meta-analysis of various types of positive psychology 60 
interventions (Bolier et al., 2013) showed overall modest effects of interventions on measures of 61 
depression and wellbeing (standardised mean difference 0.20 to 0.34).  The authors noted that many 62 
studies were of low methodological quality, and only a small number were aimed at participants with 63 
psychosocial problems (e.g. depressive symptoms). There were indications of greater effects from 64 
interventions delivered individually and over a longer duration (>8 weeks), in samples referred from 65 
clinical settings, and in samples presenting with psychosocial problems. Sample attrition ranged from 66 
0% to 29% in the seven studies that included samples with psychosocial problems. The authors 67 
recommended that further high quality research be undertaken with diverse (clinical) populations, 68 
and in countries and cultures outside North America. 69 
5 
 
We believe there is a good rationale to investigate the potential benefits of positive 70 
psychotherapy approaches in the context of ABI rehabilitation (Evans, 2011). Many people cope 71 
well, make adjustments, and experience positive psychological growth after brain injury (Rogan, 72 
Fortune, & Prentice, 2013). It is possible that goal-directed rehabilitation could be enhanced by 73 
focusing more explicitly on maximising wellbeing, using a positive psychology framework. If there 74 
were evidence of benefit, we envisage that such an approach could be delivered by rehabilitation 75 
staff as part of a comprehensive, individualised rehabilitation programme. One study to date 76 
(Andrewes, Walker, & O'Neill, 2014) has investigated the application of positive psychotherapy 77 
exercises in an in-patient ABI rehabilitation setting, but there has been no research in out-patient 78 
settings. Development and evaluation of novel psychological interventions should proceed 79 
incrementally, beginning with research on feasibility and acceptability, and including detailed pilot 80 
research to inform the design and conduct of controlled efficacy evaluations (Craig et al., 2008). We 81 
therefore undertook this pilot study with the aim of investigating the feasibility of a brief positive 82 
psychotherapy intervention within a randomised controlled trial (RCT) context, with out-patient ABI 83 
survivors experiencing emotional distress. In view of the lack of previous literature on the use of 84 
positive psychology assessment tools in this clinical population, we also wished to investigate the 85 
reliability of wellbeing measures. The present study was not designed to determine the efficacy of 86 
the intervention; rather, our objective was to gather essential data to plan future trials in this area.  87 
 88 
Primary research question 89 
(i) What are the likely recruitment, adherence and retention rates over 20 weeks for a trial comparing 90 
brief positive psychotherapy versus treatment as usual (TAU) in an out-patient setting for patients 91 
with ABI and emotional distress? 92 
 93 
Secondary research questions 94 
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(ii) Is a brief positive psychotherapy intervention feasible to deliver in an out-patient setting with 95 
patients presenting with emotional distress following ABI? 96 
(iii) Are positive psychology assessment tools reliable in people with ABI? 97 
(iv) Is a full-scale RCT of brief positive psychotherapy indicated, and if so, what is the required 98 
sample size? 99 
 100 
Methods 101 
This was a two-arm, parallel group, single-blind pilot RCT, comparing brief positive psychotherapy 102 
plus TAU (intervention) versus TAU only (control). Reporting follows CONSORT guidelines for 103 
non-pharmacologic treatment interventions (Boutron et al., 2008). Figure 1 shows participant flow 104 
through the study. Recruitment took place between June 2013 and May 2014, and follow-up was 105 
completed by October 2014. A favourable ethical opinion was given by the West of Scotland 106 
Research Ethics Service (ref. 13/WS/0049). The study was registered with the UK Clinical Research 107 
Network (ref. 14302) and ClinicalTrials.gov (ref. NCT01867684). 108 
 109 
[Figure 1 about here] 110 
 111 
Participants 112 
Adults aged 18 or over were recruited from stroke out-patient clinics and the stroke psychology 113 
service out-patient waiting list in NHS Greater Glasgow & Clyde, and from the Glasgow Community 114 
Treatment Centre for Brain Injury (CTCBI). 115 
Inclusion criteria: 116 
- Diagnosis of acquired, non-progressive brain injury (confirmed by the local clinician based 117 
on clinical and/or radiological evidence); 118 
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- Between 3 and 12 months post-injury at time of recruitment (subsequently extended up to 36 119 
months post-injury to accommodate late first-time referrals to the recruiting services); 120 
- Presence of emotional distress (score in moderate or above range on at least one sub-scale of 121 
the Depression Anxiety Stress Scales; DASS-21) (Lovibond & Lovibond, 1995); 122 
- Medically stable (based on opinion of local clinician); 123 
- Able to consent to research. 124 
Exclusion criteria: 125 
- Significant communication impairments that would preclude participation; 126 
- Diagnosis of mild traumatic brain injury; 127 
- Comorbid developmental learning disability or degenerative neurological condition.  128 
Pre-injury history of mood disorder did not lead to exclusion. 129 
 130 
Materials and Procedure 131 
Figure 2 shows the schedule of assessments. 132 
Recruitment and screening 133 
Potentially eligible patients were informed about the study by a clinician in the out-patient setting or 134 
via a letter from the stroke psychology service. Patients who expressed interest met with the research 135 
assistant (RA), gave written informed consent, and were screened to determine eligibility, including 136 
administration of the DASS-21 to measure emotional distress and the Frenchay Aphasia Screening 137 
Test (Enderby, Wood, & Wade, 2013) to ascertain adequate level of communication ability. The 138 
DASS-21 scores from this assessment also served as baseline measures in the study.  139 
Baseline measures and randomisation (Week 0) 140 
Either on the same day as the screening assessment or within the following 10 days, participants 141 
completed further baseline assessment measures: Test of Premorbid Functioning (ToPF) (Wechsler, 142 
2011a); Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (Randolph, 143 
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1998); Digit Span task from the Wechsler Adult Intelligence Scale 4th edition (WAIS-IV) 144 
(Wechsler, 2010); Similarities task from the Wechsler Abbreviated Scale of Intelligence (WASI-II) 145 
(Wechsler, 2011b); letter fluency (Tombaugh, Kozak, & Rees, 1999); Awareness Questionnaire 146 
(AQ) (Sherer, 2004); and Mayo-Portland Adaptability Inventory (MPAI-4) (Malec, 2005). Informant 147 
versions of the AQ and MPAI-4 and the Modified Caregiver Strain Index (M-CSI) (Thornton & 148 
Travis, 2003) were administered to an appropriate informant (this was optional, depending on 149 
participant preference). 150 
The Authentic Happiness Inventory (AHI) (Peterson, 2005) and a short inventory of 151 
Signature Strengths (based on the Brief Strengths Test) (Peterson, 2004) were administered to 152 
participants at baseline and again within one week (prior to commencing the intervention), to 153 
ascertain test-retest reliability of these positive psychology tools in this clinical population. The AHI 154 
includes 24 items assessing pleasure, meaning and engagement, with each item represented by a 155 
group of multiple-choice statements (e.g. 1 = ‘My life does not have any purpose or meaning’ to 5 = 156 
‘I have a very clear idea about the purpose or meaning of my life’). The AHI has previously been 157 
reported to have high internal consistency (α = 0.92 in healthy young adults) (Schiffrin & Nelson, 158 
2010). It has been successfully used with participants with brain injury in one study (Andrewes et al., 159 
2014), but psychometric properties were not reported.  The Signature Strengths inventory was a list 160 
of brief descriptions of 24 positive character attributes. Participants used an iterative card-sorting 161 
procedure to rank the attributes, to produce a final list of the ‘top five’ signature strengths that they 162 
perceived to be true of themselves. This was not administered as a study outcome variable, but rather 163 
as a necessary pre-requisite to the exercises that would be introduced during the intervention. 164 
Participants were also asked to rate the acceptability of both the AHI and Signature Strengths 165 
inventories.  166 
Following baseline assessment, participants were randomly allocated to study intervention or 167 
control arm. 168 
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Intervention phase (Weeks 1 to 8 inclusive) 169 
Participants in the control arm received usual care within the clinical service. The content of usual 170 
care was not standardised; input varied between services and participants, but all participants could 171 
access clinical psychology input if required. Participants in the intervention arm received a brief 172 
positive psychotherapy intervention delivered over eight weeks, in addition to accessing usual care 173 
within the clinical service. The study intervention followed a manualised programme designed by the 174 
research team and based on aspects of Rashid and Seligman’s programme (Rashid & Seligman, 175 
2013), incorporating psychoeducation about ABI and positive psychology (Week 1), a range of 176 
therapeutic exercises and homework focused on using signature character strengths and reflecting on 177 
positive events (Weeks 2 to 7 inclusive, with mid-point review at Week 4), and final review and plan 178 
for maintenance (Week 8). The topics and exercises were based on Seligman’s PERMA framework 179 
(Seligman, 2011) and conceptualisation of the ‘Full Life’, and included character strengths, gratitude, 180 
savouring, optimism, hope, personal growth, and the ‘gift of time’. Care was taken to ensure that the 181 
treatment principles took into account the likely social and health-related challenges faced by the 182 
study population. Negative circumstances and perceptions were acknowledged and discussed but the 183 
treatment programme avoided cognitive therapy techniques, instead focusing on realistic goal-setting 184 
and action planning. The trial therapist liaised with the patient’s clinical service if appropriate, to 185 
ensure that psychological needs that were beyond the scope of the study intervention could be 186 
addressed as part of usual clinical treatment. The intervention was delivered on a one-to-one basis 187 
once per week within a clinical out-patient setting by one trial therapist (J.P.), who held a psychology 188 
PhD but no formal qualifications in psychological therapy. Participants’ travel expenses were paid. A 189 
standard treatment workbook was provided for use by participants during and between appointments, 190 
containing session summaries and space to record individualised homework information. An 191 
individualised method of prompting the completion of homework (e.g. notes, alarms etc) was agreed 192 
upon. Feasibility and acceptability of the treatment programme were measured by recording 193 
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appointments attended, homework tasks completed, trial therapist’s ratings of the feasibility of the 194 
session content, and participants’ opinions of the programme (Likert scales and comments, unseen 195 
by the trial therapist). 196 
Interim and follow-up measures (Weeks 5, 9 and 20) 197 
Participants in both study arms completed the DASS-21 and AHI at Weeks 5, 9 and 20. At Week 20 198 
only, the MPAI-4 was re-administered, and informants were also asked to complete this and the M-199 
CSI. These assessments were administered by a second RA, blinded to allocation, by post or by 200 
telephone depending on participant preference. A telephone reminder was provided if postal 201 
materials had not been returned after one week.  202 
 203 
[Figure 2 about here] 204 
 205 
Summary of outcome measures 206 
Primary outcome measures: 207 
- Recruitment rate; treatment adherence; and sample retention at 20 weeks from baseline. 208 
Secondary outcome measures: 209 
- Test-retest reliability of AHI and Signature Strengths inventory; 210 
- Change in DASS-21 scores at 20 weeks from baseline; 211 
- Changes in AHI, MPAI-4 and M-CSI scores at 20 weeks from baseline; 212 
- Ratings of participants’ and therapist’s experience of treatment delivery. 213 
The 20-week assessment was chosen a priori as the primary end-point because this would provide a 214 
more robust test of efficacy in a future full-scale trial than the immediate post-intervention measures. 215 
 216 
Treatment fidelity 217 
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All intervention sessions were audio-recorded, and a subsample of these (three randomly chosen 218 
recordings from each of the eight treatment sessions in the programme) were rated by the chief 219 
investigator (J.J.E.). Ratings were made with reference to the treatment manual, according to a three-220 
point scale (content consistent with protocol for stage of therapy; content partially consistent but 221 
evidence of deviation into other unrelated areas or therapeutic methods; content largely inconsistent 222 
with protocol for stage of therapy). A clinical neuropsychologist (B.C.) provided regular clinical 223 
supervision input to the trial therapist. Both the chief investigator and supervisor attended positive 224 
psychotherapy training delivered by original developer Tayyab Rashid prior to study 225 
commencement.  226 
 227 
Randomisation and bias prevention 228 
Stratified randomisation with blocking was used to allocate participants to two groups of equal size, 229 
stratified by service setting (stroke versus CTCBI). Because service setting was a proxy for injury 230 
type (stroke versus non-stroke) and for the nature of usual care that would be available to 231 
participants, either of which could have influenced outcomes, including this as a stratification factor 232 
ensured these aspects would be balanced across the intervention and control groups. The allocation 233 
system was managed by the Robertson Centre for Biostatistics and was accessed via an automated 234 
telephone service after the baseline assessment had been completed. Screening, baseline assessments, 235 
allocation and interventions were carried out by one RA (who was blinded to randomisation block 236 
length), and the interim and follow-up measures were administered by a second RA, each of whom 237 
was blind to the other’s findings. The second RA was blind to participant allocation; a standard script 238 
was used to prevent unblinding during follow-up telephone calls, and postal materials included clear 239 
instructions to participants not to reveal treatment allocation information.  240 
 241 
Sample size and statistical methods 242 
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Taking into account available service information about estimated numbers of patients meeting study 243 
criteria during the planned recruitment period, and typical attrition rates from psychological therapy 244 
(Wierzbicki & Pekarik, 1993), we estimated that up to 30 participants would be randomised to each 245 
study arm and that 70% (95% confidence interval [CI] 58%-82%) would be retained to the 20-week 246 
endpoint. However, determining the actual recruitment and retention rate was the primary aim of the 247 
study.  248 
Data were analysed using SAS software, following a detailed analysis plan. Recruitment, 249 
adherence and retention rates were summarised as percentages. An intra-class correlation coefficient 250 
(ICC) was calculated to determine test-retest reliability of the AHI; 95% CI was generated using a 251 
non-parametric bootstrap procedure with 500 replicates. Percent test-retest agreement on the 252 
Signature Strengths inventory was reported. Analyses were conducted on an intention to treat basis: 253 
participants were analysed in the groups to which they had been allocated (regardless of adherence), 254 
and missing data were not imputed. The study was not designed to have power to detect significant 255 
differences in outcomes between the two study arms. 256 
 257 
Results 258 
Characteristics of the sample 259 
A total of 76 patients expressed interest, of whom n = 9 were ineligible, n = 17 declined to 260 
participate, and n = 13 lost contact, leaving n = 37 who enrolled in the study. A CONSORT 261 
flowchart is given in Figure 3. This shows that n = 27 completed baseline assessments and were 262 
randomised. Table 1 shows the baseline demographic and clinical characteristics of the intervention 263 
and control groups. The control group was older on average than the intervention group; this was due 264 
to the inclusion of one 25-year old in the intervention group. There were more men than women in 265 
both groups. The majority of participants were recruited from stroke services, and the most common 266 
type of injury was ischaemic stroke. Median time since injury was just under six months. Seven of 267 
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13 control participants and six of 14 intervention participants were receiving psychological treatment 268 
outside the study. Two-thirds of the control group and one third of the intervention group self-269 
reported that they were taking psychotropic medications. Of those taking psychotropic medications, 270 
two were taking both an antidepressant and a sedative. The remainder were taking one medication, 271 
most commonly a selective serotonin reuptake inhibitor. 272 
 273 
[Figure 3 about here] 274 
[Tables 1 and 2 about here] 275 
 276 
 Table 2 shows the cognitive measures and self- and informant-reported questionnaires at 277 
baseline. The mean DASS-21 scores for Depression and Anxiety were in the severe range and the 278 
mean Stress score was in the moderate-severe range, with some indication of poorer scores in the 279 
control group. Participants rated their overall disability level on the MPAI-4 in the moderate-severe 280 
range relative to a typical ABI comparison group. Where AQ ratings were available for both 281 
participants and informants (n = 14), score differences indicated that the control participants’ 282 
perception of their functioning was better than informants’ perceptions, whereas the reverse was true 283 
for those in the intervention arm. Cognitive scores were in the low average to average range on most 284 
measures, with slightly better performance seen in the intervention group.  285 
 286 
Acceptability and reliability of positive psychology measures 287 
At baseline, participants rated their experience of completing the AHI questionnaire and Signature 288 
Strengths inventory on 7-point Likert scales, where lower scores indicated more favourable opinions. 289 
Median ratings of ease, length and relevance of the AHI were 3 or lower. Several participants 290 
commented that item 15 on the AHI did not apply to them because it asked about “work (paid or 291 
unpaid)” and so they did not feel able to select an answer. For this reason, all AHI scores reported 292 
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here exclude item 15 from the mean calculation. A median Likert rating of 2 was given for each 293 
opinion (ease, length and relevance) of the Signature Strengths inventory. Participants commented 294 
that they found the descriptions and card-sorting procedure easy to understand, but struggled to 295 
narrow their choice down to five signature strengths. 296 
The AHI and Signature Strengths exercise were re-administered after a median of 9.5 days 297 
(25th, 75th percentile = 7.0, 15.5; n = 24) to ascertain test-retest reliability. The ICC coefficient for 298 
the AHI mean score was 0.86 (95% CI = 0.81, 0.91). The median percentage agreement for the top 299 
five Signature Strengths was 60% (25
th
, 75
th
 percentile = 40%, 60%).  300 
 301 
Feasibility and acceptability of the brief positive psychotherapy intervention 302 
Of the 14 participants randomised to the intervention arm, two declined to commence treatment 303 
because of perceived lack of time. Of the 12 who commenced, n = 8 attended all eight planned 304 
sessions. Two participants discontinued treatment after the first session: one ceased contact with the 305 
therapist, and one informed the therapist that they had found it distressing talking about difficulties 306 
and did not wish to continue. One participant ceased treatment after five sessions, due to significant 307 
illness. One participant ceased treatment after six sessions; this person had dropped out of contact 308 
with the therapist repeatedly throughout the treatment period, leading to long gaps between 309 
appointments, and they eventually informed the team that they did not wish to complete. Participants 310 
who did not complete treatment were still sent follow-up questionnaires, unless they indicated that 311 
they no longer wished to receive them.   312 
Completion rates for assigned homework were high: across all participants who attended at 313 
least one session that involved homework, 74% of assigned tasks were fully or partly completed. All 314 
eight participants who attended the full treatment programme completed at least 70% of their 315 
assigned homework.  316 
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The average length of each session in the programme varied, with Session 7 being the 317 
shortest (median 25 minutes; 25th, 75th percentile = 23, 36) and Session 5 being the longest (median 318 
43 minutes; 25th, 75th percentile = 33, 46). The trial therapist rated her perception of the feasibility 319 
of each session with each participant (total of 77 sessions). Overall, 73 sessions (94.8%) were rated 320 
as feasible. Four were rated as partly feasible, with cognitive impairment, distress and fatigue noted 321 
as reasons for this. The chief investigator rated n = 24 randomly selected session recordings for 322 
fidelity; all were rated ‘consistent with protocol’. 323 
At the end of Session 4 and Session 8, participants attending treatment completed a feedback 324 
form (unseen by the therapist) regarding their opinion of the convenience of appointments, relevance 325 
of treatment to their concerns, ease of using workbooks within sessions, and ease of homework 326 
completion (7-point Likert scales with lower ratings being more favourable). Median ratings for all 327 
aspects at both time-points were 2.5 or lower. The majority of comments were positive, with 328 
examples as follows: 329 
“Great experience. Feel privileged to be in 'chosen' group and feel I have benefited greatly 330 
from sessions. Will try to build in maintenance and keep positive outcome ongoing.” (ID 331 
1013).  332 
“Exactly what I needed after suffering a stroke at a young age - confidence and fear play a 333 
massive part - this treatment has been invaluable.” (ID 1024). 334 
Participants were able to use the workbook and homework diaries but commented that lack of time 335 
and motivation impacted on homework completion. Use of frequent recapping and review sessions 336 
were viewed as helpful.  337 
 338 
Retention to Week 20 endpoint 339 
As Figure 2 shows, five participants were lost from each study arm; retention was 62% in the control 340 
group and 64% in the intervention group (63% overall). Four control participants and three 341 
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intervention participants failed to return their Week 20 questionnaires and were considered lost to 342 
follow-up. One control participant withdrew between baseline and Week 5, due to moving out of the 343 
area. One intervention participant withdrew between baseline and Week 5, stating they had changed 344 
their mind, and one intervention participant withdrew between Week 9 and Week 20 due to illness.  345 
 346 
Success of blinding 347 
All post-baseline outcome measures were processed by a blinded assessor, who guessed allocation at 348 
the end of the study. These guesses were at near-chance level: 53.8% of treatment participants and 349 
58.3% of control participants were guessed correctly.  350 
 351 
[Table 3 about here] 352 
 353 
Sample size calculation for full-scale trial 354 
Table 3 summarises the change scores in the sample as a whole between baseline and the primary 355 
endpoint, Week 20. The variance in these change scores can be used as the basis for a sample size 356 
calculation for a full-scale trial. Further information regarding differences in change scores between 357 
the treatment and control groups is given in the Supplement. 358 
The DASS-21 Depression score would be the primary outcome of interest in a future full-359 
scale trial. A decrease of 7 points on this measure would mean that everyone scoring in the moderate 360 
or severe ranges would drop into the range below. Based on the SD of the overall change score in 361 
this pilot trial (10.84), a full-scale trial comparing brief positive psychotherapy versus TAU would 362 
require n = 39 per group at end-point to detect a significant difference in change scores of 7 points 363 
(two-tailed alpha = 0.05, power = 0.80). Assuming 63% retention, n = 62 would be required per 364 
group (total n = 124). 365 
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Given the known non-specific benefits of receiving a trial intervention and additional contact 366 
from the research team, it would be valuable to consider a trial design comparing the intervention 367 
with an attention control rather than TAU only. In this case, a smaller decrease on DASS-21 368 
Depression would be expected. A two-arm trial of this type would require n = 75 per group at end-369 
point to detect a significant difference in change scores of 5 points (two-tailed alpha = 0.05, power = 370 
0.80). Assuming 63% retention, n = 120 would be required per group (total n = 240). Alternatively, a 371 
three-arm trial could be undertaken to compare the study intervention against both an attention 372 
control and TAU only. This would require n = 100 per group at end-point to detect a significant 373 
difference in change scores of 5 points (two-tailed alpha = 0.017, power = 0.80). Assuming 63% 374 
retention, n = 159 would be required per group (total n = 477). 375 
 376 
Discussion 377 
Recruitment to this pilot trial was challenging, but we succeeded in recruiting a small sample which 378 
was representative demographically and clinically of patients with ABI, most of whom were stroke 379 
survivors. Important information was gathered regarding recruitment strategy, and good working 380 
relationships were established with a range of recruiting services. We gained an understanding of 381 
reasons for ineligibility of potential participants; in both stroke and brain injury services this was 382 
often because of length of time since injury or lack of clear evidence of definite ABI. We took steps 383 
to address the issue of time since injury by increasing the upper limit from 12 months to 36 months, 384 
but a large number of patients were beyond even this time frame, especially in the CTCBI service. In 385 
future it may be possible to make contact with patients earlier in the post-injury pathway by 386 
recruiting from in-patient services at time of discharge, and/or by recruiting from third sector 387 
organisations.  388 
A key study output was the brief positive psychotherapy treatment package, including 389 
manual, workbooks and supporting materials. The treatment programme was feasible to deliver and 390 
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acceptable to patients, with favourable feedback regarding usability and relevance. Therapist fidelity 391 
was excellent, although the study would have benefited from the inclusion of additional treatment 392 
process measures, e.g. of client expectations and therapeutic alliance. Homework completion rates 393 
were good, despite the cognitive challenges of self-directed task completion and independent 394 
reflection on psychological concepts.  395 
The dropout rate was comparable with typical rates for psychological therapies, which have 396 
previously been estimated as 20% to 47% (Swift & Greenberg, 2012; Wierzbicki & Pekarik, 1993), 397 
and was unsurprising in this clinical population where disability and comorbidity are common. 398 
Sample attrition at endpoint was similar in both study arms. Previous studies of one-to-one positive 399 
psychology interventions in samples with emotional distress have reported attrition rates of 0% to 400 
20% in the intervention group and 40% in the control group (Bolier et al., 2013). There was no 401 
indication that treatment dropout was related to the positive psychotherapy package specifically; 402 
distress was cited by one person as a reason for dropout, but in that particular case it was felt that the 403 
participant would not have engaged with any talking therapy. We acknowledge that a positive 404 
psychotherapy approach may not be well-received by some patients, especially if they perceive the 405 
intervention as not addressing the negative aspects of their experiences; we aimed to manage 406 
expectations and maximise engagement by explaining in the first treatment session that this was not 407 
a simplistic ‘positive thinking’ intervention, and by encouraging the setting of realistic goals and 408 
action plans throughout treatment. It would be important in future studies to focus in more detail on 409 
issues of therapeutic engagement, in order to improve sample retention during the intervention phase. 410 
A future trial would also benefit from a staged approach to maximise sample follow-up, moving 411 
proactively from postal contact to telephone administration and possibly face-to-face visits 412 
depending on individual participant needs. Reducing treatment dropout and non-response at follow-413 
up would increase study power and reduce the sample recruitment load of a future trial. 414 
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Some limitations were found regarding the feasibility of the AHI measure, in particular one 415 
item assessing satisfaction with work. Because this measure is scored as a mean across items, it was 416 
possible to modify this for use here by excluding that item. Test-retest reliability of the AHI was 417 
high, and it has good potential as a secondary outcome to assess psychological wellbeing alongside 418 
the DASS-21. The Signature Strengths rating showed lower test-retest agreement. This was not 419 
intended to be used as an outcome measure, however, but rather as an exercise to inform goal-setting 420 
in treatment. Participants reported that this rather abstract measure was understandable and relevant 421 
to them.   422 
A limitation of the study was the self-report nature of the follow-up questionnaires. Although 423 
these were handled by a blinded assessor, they reflect subjective reporting by unblinded participants. 424 
A future trial would benefit from the addition of externally rated outcome measures.  425 
We conclude that a full-scale RCT of brief positive psychotherapy for emotional distress 426 
following ABI is justified and feasible. The treatment package would be largely identical, and we 427 
therefore expect to be able to incorporate data from this pilot study into a future larger analysis. This 428 
will ensure maximum value from the present study, and contribute to the efficiency of a future trial. 429 
Although the sample size here was small, we obtained sufficient information about recruitment 430 
strategy, and detailed feedback from those participants who did complete treatment, to allow us to be 431 
confident about designing and conducting a full-scale trial with a high chance of success. This will 432 
require a multi-centre approach to achieve adequate sample sizes to detect significant treatment 433 
effects.  434 
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Table 1 Demographic and clinical characteristics of the sample at baseline. 
  Overall Control Intervention 
Age (years) n (missing) 27 (0) 13 (0) 14 (0) 
 Median (25
th, 75th percentile) 57.0 (49.0, 61.0) 58.0 (56.0, 68.0) 54.0 (46.0, 59.0) 
Gender n (missing) 27 (0) 13 (0) 14 (0) 
 Male n (%) 17 (63.0) 8 (61.5) 9 (64.3) 
Years of education n (missing) 27 (0) 13 (0) 14 (0) 
 Median (25th, 75th percentile) 11.0 (11.0, 15.0) 11.0 (11.0, 12.0) 11.0 (11.0, 15.0) 
Service setting n (missing) 27 (0) 13 (0) 14 (0) 
 CTCBI n (%) 3 (11.1) 1 (7.7) 2 (14.3) 
 Stroke n (%) 24 (88.9) 12 (92.3) 12 (85.7) 
Diagnosis category n (missing) 27 (0) 13 (0) 14 (0) 
 CVA (infarct) n (%) 22 (81.5) 11 (84.6) 11 (78.6) 
 CVA (haemorrhagic) n (%) 2 (7.4) 1 (7.7) 1 (7.1) 
 Other ABI n (%) 3 (11.1) 1 (7.7) 2 (14.3) 
Time since injury 
(months) 
n (missing) 27 (0) 13 (0) 14 (0) 
 Median (25th, 75th percentile) 5.7 (3.1, 8.4) 5.6 (3.1, 8.4) 5.8 (3.5, 8.2) 
Seeing a psychologist n (missing) 27 (0) 13 (0) 14 (0) 
 Yes n (%) 13 (48.1) 7 (53.8) 6 (42.9) 
Taking a 
psychotropic 
medication 
n (missing) 26 (1) 12 (1) 14 (0) 
 Yes n (%) 13 (50.0) 8 (66.7) 5 (35.7) 
Informant typea n (missing) 18 (9) 8 (5) 10 (4) 
 Spouse / partner n (%) 14 (77.8) 5 (62.5) 9 (90.0) 
 Parent n (%) 1 (5.6) 0 1 (10.0) 
 Child n (%) 2 (11.1) 2 (25.0) 0 
 Friend n (%) 1 (5.6) 1 (12.5) 0 
 
Note: ABI, acquired brain injury; CTCBI, Community Treatment Centre for Brain Injury; CVA, 
cerebrovascular accident. 
a
 Inclusion of an informant in the study was optional. 
 
  
25 
 
Table 2 Cognitive and questionnaire measures at baseline. 
  Overall Control Intervention 
ToPF estimated IQ n (missing) 26 (1) 12 (1) 14 (0) 
 Median (25th, 75th percentile) 99.00 (94.30, 106.0) 96.60 (92.35, 108.5) 101.0 (95.40, 106.0) 
RBANS Immediate 
memory 
n (missing) 27 (0) 13 (0) 14 (0) 
 Mean (SD) 83.15 (15.49) 80.15 (16.73) 85.93 (14.30) 
RBANS Delayed 
memory 
n (missing) 24 (3) 12 (1) 12 (2) 
 Mean (SD) 92.75 (11.62) 90.17 (9.04) 95.33 (13.64) 
RBANS Attention n (missing) 26 (1) 13 (0) 13 (1) 
 Mean (SD) 93.31 (16.07) 89.54 (16.08) 97.08 (15.77) 
RBANS Language n (missing) 27 (0) 13 (0) 14 (0) 
 Mean (SD) 91.96 (11.56) 89.15 (8.77) 94.57 (13.45) 
RBANS Visuospatial n (missing) 25 (2) 12 (1) 13 (1) 
 Mean (SD) 99.00 (13.00) 95.33 (11.77) 102.4 (13.60) 
Longest digit span 
forward 
n (missing) 27 (0) 13 (0) 14 (0) 
 Median (25th, 75th percentile) 7.00 (5.00, 8.00) 7.00 (5.00, 7.00) 7.00 (5.00, 8.00) 
Longest digit span 
backward 
n (missing) 27 (0) 13 (0) 14 (0) 
 Median (25th, 75th percentile) 4.00 (3.00, 6.00) 4.00 (3.00, 5.00) 4.50 (4.00, 6.00) 
Letter fluency total n (missing) 27 (0) 13 (0) 14 (0) 
 Median (25th, 75th percentile) 32.00 (25.00, 41.00) 26.00 (23.00, 37.00) 32.50 (28.00, 41.00) 
Similarities T-score n (missing) 27 (0) 13 (0) 14 (0) 
 Mean (SD) 44.44 (8.25) 45.31 (11.39) 43.64 (3.88) 
DASS-21 Depression n (missing) 26 (1) 12 (1) 14 (0) 
 Mean (SD) 24.19 (10.51) 27.58 (9.55) 21.29 (10.74) 
DASS-21 Anxiety n (missing) 27 (0) 13 (0) 14 (0) 
 Mean (SD) 19.26 (9.51) 21.08 (9.37) 17.57 (9.68) 
DASS-21 Stress n (missing) 27 (0) 13 (0) 14 (0) 
 Mean (SD) 25.93 (7.37) 28.15 (6.08) 23.86 (8.06) 
AHI mean scorea n (missing) 27 (0) 13 (0) 14 (0) 
 Mean (SD) 2.40 (0.43) 2.39 (0.45) 2.41 (0.44) 
AQ score differenceb,c n (missing) 14 (13) 7 (6) 7 (7) 
 Median (25th, 75th percentile) 2.00 (-7.00, 4.00) 3.00 (1.00, 7.00) -7.00 (-13.0, 3.00) 
MPAI-4 total 
(participant) 
n (missing) 26 (1) 13 (0) 13 (1) 
 Mean (SD) 54.23 (5.32) 55.92 (5.99) 52.54 (4.10) 
MPAI-4 total 
(informant)
c 
n (missing) 10 (17) 4 (9) 6 (8) 
 Mean (SD) 49.00 (11.74) 44.00 (15.38) 52.33 (8.52) 
26 
 
M-CSIc n (missing) 12 (15) 6 (7) 6 (8) 
 Median (25th, 75th percentile) 5.50 (2.50, 9.00) 5.00 (1.00, 13.00) 7.00 (4.00, 9.00) 
 
Note: AHI, Authentic Happiness Inventory; AQ, Awareness Questionnaire; DASS-21, Depression 
Anxiety Stress Scales short form; IQR, interquartile range; M-CSI, Modified Caregiver Strain Index; 
MPAI-4, Mayo-Portland Adaptability Inventory; RBANS, Repeatable Battery for the Assessment of 
Neuropsychological Status; SD, standard deviation; ToPF IQ, Test of Premorbid Functioning 
intelligence quotient.  
a
 Score from first baseline administration, excluding item 15. 
b
 AQ score difference was calculated by subtracting the informant score from the patient score; 
positive values indicate better perceived functioning by the patient relative to the informant. 
c
 Inclusion of an informant in the study was optional. 
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Table 3 Change scores on outcome measures from baseline to Week 20, for both groups 
combined. 
 
 Mean change score SD n 
DASS-21 Depression -5.87 10.84 15 
DASS-21 Anxiety -4.80 9.85 15 
DASS-21 Stress -5.20 5.80 15 
AHI mean score 0.02 0.47 17 
MPAI-4 total (participant) -1.89 6.95 9 
MPAI-4 total (informant)a 0.40 10.11 5 
M-CSIa -3.00 2.16 4 
 
Note: AHI, Authentic Happiness Inventory; DASS-21, Depression Anxiety Stress Scales short form; 
M-CSI, Modified Caregiver Strain Index; MPAI-4, Mayo-Portland Adaptability Inventory; SD, 
standard deviation. Negative values indicate improvement, except AHI where positive value 
indicates improvement. AHI mean scores exclude item 15. The mean interval between baseline and 
endpoint was 23.3 weeks (SD = 2.3). 
a
 Inclusion of an informant in the study was optional. 
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Figure legends 
 
Figure 1  Participant flow through study. 
Note: AHI, Authentic Happiness Inventory; Ax, assessment; DASS-21, Depression Anxiety Stress 
Scales short form; M-CSI, Modified Caregiver Strain Index; MPAI-4, Mayo-Portland Adaptability 
Inventory; TAU, treatment as usual. 
 
 
Figure 2 Schedule of assessments.  
Note: AHI, Authentic Happiness Inventory; AQ, Awareness Questionnaire; DASS-21, Depression 
Anxiety Stress Scales short form; FAST, Frenchay Aphasia Screening Test; M-CSI, Modified 
Caregiver Strain Index; MPAI-4, Mayo-Portland Adaptability Inventory; RBANS, Repeatable 
Battery for the Assessment of Neuropsychological Status; ToPF, Test of Premorbid Functioning; 
WAIS-IV, Wechsler Adult Intelligence Scale 4
th
 edition; WASI-II, Wechsler Abbreviated Scale of 
Intelligence 2
nd
 edition. 
 
 
Figure 3  CONSORT flowchart. 
Note: The sample size for analysis (total n = 15) refers to the analysis of sample size calculations for 
a future full-scale trial, based on the DASS-21 outcome data. The analysis sample for other results 
reported was n = 17.  
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Supplementary Results 
Change on outcome measures at primary endpoint (Week 20) 
This study was not designed or powered to test the efficacy of the positive psychotherapy intervention. We 
include the additional results below to illustrate how such an analysis would be undertaken in a future full-
scale trial with adequate sample size.  
Table S1 below shows differences in mean change scores between baseline and Week 20 on each 
outcome measure, adjusted using analysis of covariance for service setting (stroke vs CTCBI) and baseline 
scores. Participants were grouped on an intention to treat basis. Mean time between assessments was 23.3 
weeks (SD = 2.3). Participants with complete questionnaire data at both timepoints were included. Results 
for the M-CSI and the informant MPAI-4 are not reported due to very small sample sizes.  
 
Table S1 Differences in change scores between baseline and Week 20. 
 
 Control 
change score  
M (SD) 
Intervention change 
score  
M (SD) 
Adjusted mean 
differencea  
(95% CI) 
Effect size d 
(95% CI) 
p Control 
n 
Intervention 
n 
DASS-21 
Depression 
-3.71 (10.16) -7.75 (11.73) -7.96 (-19.7, 3.78) 0.73 (-0.34, 1.80) 0.250 7 8 
DASS-21 
Anxiety 
0.57 (10.63) -9.50 (6.57) -9.64 (-16.6, -2.66) 1.09 (0.30, 1.88) 0.030 7 8 
DASS-21 
Stress 
-2.29 (5.35) -7.75 (5.18) -5.78 (-10.9, -0.69) 1.10 (0.13, 2.06) 0.066 7 8 
AHI mean 
score 
-0.23 (0.32) 0.24 (0.49) 0.45 (0.08, 0.83) 1.11 (0.20, 2.02) 0.050 8 9 
MPAI-4 total 
(participant) 
0.50 (8.89) -3.80 (5.22) -3.07 (-16.7, 10.53) 0.42 (-1.44, 2.29) 0.676 4 5 
Note: AHI, Authentic Happiness Inventory; CI, confidence interval; DASS-21, Depression Anxiety Stress Scales short form; M, mean; MPAI-4, 
Mayo-Portland Adaptability Inventory; SD, standard deviation. Decreases on scores indicate improvement, except AHI where increase indicates 
improvement. Positive d values favour intervention. AHI mean scores exclude item 15.  
a Adjusted using analysis of covariance for service setting (stroke vs CTCBI) and baseline scores. 
 
A sensitivity analysis was carried out including imputed scores for missing questionnaire items; this resulted 
in a small increase in sample sizes but did not alter the substance of the results. It should be noted that 
although Week 20 was intended to be a follow-up assessment (12 weeks after the end of the treatment 
phase), several intervention participants had completed their treatment programme later than planned as a 
result of appointment cancellations and breaks in contact with the therapist. Consequently, the effects 
reported above may be post-treatment rather than follow-up effects for some participants.  
